← back to search

Bettina Gisslinger

Ospedale San Bortolo · AT
Area of research
Genetics · Hematology
Research interest
Research interests include Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Eosinophilic Disorders and Syndromes, and Acute Myeloid Leukemia Research.
h-index
33
citations
6,775
works
124
NIH funding
primary concept
Polycythemia vera
email

Recent publications

Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases
American Journal of Hematology 2019cited by 70position: middledoi
The effect of arterial hypertension on thrombosis in low‐risk polycythemia vera
American Journal of Hematology 2016cited by 66position: middledoi
In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology
Blood 2014cited by 155position: middledoi
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
Leukemia 2013cited by 667position: middledoi
Masked polycythemia Vera (mPV): Results of an international study
American Journal of Hematology 2013cited by 142position: middledoi
Masked polycythemia vera diagnosed according to WHO and BCSH classification
American Journal of Hematology 2013cited by 76position: middledoi
A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment
Blood 2012cited by 264position: middledoi
Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome
Blood 2012cited by 106position: middledoi
Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis
Blood 2012cited by 76position: middledoi
Leukocytosis as an important risk factor for arterial thrombosis in WHO‐defined early/prefibrotic myelofibrosis: An international study of 264 patients
American Journal of Hematology 2012cited by 60position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 8 papers (2012–2016) · 8 papers (2012–2016)Ayalew Tefferi · Mayo Clinic8 papers (2012–2016)Alessandro M. Vannucchi · All India Institute of Medical Sciences8 papers (2012–2016)Maria Luigia Randi · University of Padua8 papers (2012–2016)Heinz Gisslinger · Hôpital Saint-Louis8 papers (2012–2016)Tiziano Barbui · Ospedale Maggiore8 papers (2012–2016) · 8 papers (2012–2016)Marco Ruggeri · International Breast Cancer Study Group7 papers (2012–2016)Alessandro Rambaldi · Astellas Pharma (United States)7 papers (2012–2016)Jürgen Thiele · University Hospital Cologne5 papers (2012–2013)Leonhard Müllauer · University of Dundee5 papers (2012–2013)Francesco Passamonti · University of Insubria5 papers (2012–2014)Irene Bertozzi · Azienda Ospedaliera Universitaria Senese5 papers (2012–2014) · 5 papers (2012–2016)Francesco Rodeghiero · European Science Foundation4 papers (2012–2014)Animesh Pardanani · Yale Cancer Center3 papers (2013–2016)Naseema Gangat · Mayo Clinic in Arizona2 papers (2012–2012) · 2 papers (2013–2014)Mario Cazzola · King's College London2 papers (2013–2016)